Zobrazeno 71 - 79
of 79
pro vyhledávání: '"Katia Mancuso"'
Autor:
Michele Cavo, Annamaria Brioli, Enrica Borsi, Paola Tacchetti, Elena Zamagni, Marina Martello, Viviana Guadagnuolo, Carolina Terragna, Katia Mancuso, Lucia Pantani, Flores Dico, Beatrice Anna Zannetti, Serena Rocchi, Giovanni Martinelli
Publikováno v:
Cancer Research. 74:3884-3884
Background Although the advances in Multiple Myeloma (MM) therapy, the disease remains incurable. The existence of Myeloma Propagating Cells (MPCs) is supposed to be one of the major causes of MM drug-resistance, leading to relapse. However, very lit
Autor:
Paola Tacchetti, Katia Mancuso, Elena Zamagni, Flores Dico, Nicoletta Testoni, Marina Martello, Lucia Pantani, Giulia Marzocchi, Michele Cavo, Annamaria Brioli, Giovanni Martinelli, Carolina Terragna, Enrica Borsi, Beatrice Anna Zannetti, Serena Rocchi
Publikováno v:
Cancer Research. 74:5595-5595
Background. The TP53 tumor-suppressor gene is mutated or functionally inactivated in most human cancers. In MM, TP53 del on chr 17p13 defines a pts group with a particularly poor prognosis, even if its prevalence at diagnosis is quite low. One of the
Autor:
Giulia Marzocchi, Serena Rocchi, Michele Cavo, Annamaria Brioli, Annalisa Pezzi, Giovanni Martinelli, Katia Mancuso, Carolina Terragna, Nicoletta Testoni, Elena Zamagni, Cristina Nanni, Lucia Pantani, Beatrice Anna Zannetti, Paola Tacchetti, Stefano Fanti
Publikováno v:
ResearcherID
PET/CT is a reliable technique for assessing skeletal involvement in MM and a valuable tool at the onset of the disease for predicting outcomes in those patients who are eligible to subsequently receive autologous stem cell transplantation (ASCT). Ho
Autor:
Elena Zamagni, Carolina Terragna, Katia Mancuso, Paola Tacchetti, Beatrice Anna Zannetti, Marina Martello, Enrica Borsi, Giovanni Martinelli, Michele Cavo, Lucia Pantani, Flores Dico
Publikováno v:
Cancer Research. 73:3749-3749
Background Although the advances in Multiple Myeloma (MM) therapy, the disease remains incurable. The existence of Myeloma Propagating Cells (MPCs) is supposed to be one of the major causes of MM drug-resistance, leading to relapse. However, very lit
Autor:
Antonio Ledda, Piero Galieni, Francesco Di Raimondo, Franco Narni, Alessandro Gozzetti, Annalisa Pezzi, Antonio Lazzaro, Luciano Masini, Michele Baccarani, Lucio Catalano, Mauro Fiacchini, Nicoletta Testoni, Francesca Patriarca, Carolina Terragna, Katia Mancuso, Sonia Ronconi, Michele Cavo, Annamaria Brioli, Catello Califano, Paola Tacchetti, Silvestro Volpe, Beatrice Anna Zannetti, Elena Zamagni, Emanuele Angelucci, Claudia Cellini, Patrizia Tosi, Lucia Pantani
Publikováno v:
Blood. 120:594-594
Abstract 594 Survival of patients with multiple myeloma (MM) has been extended with the introduction of autologous stem cell transplantation (ASCT). More recently, availability of highly effective novel agents has further improved patient outcomes. H
Autor:
Letizia Canepa, Felicetto Ferrara, Pellegrino Musto, Michele Cavo, Annamaria Brioli, Serena Rocchi, Lucio Catalano, Graziella Pinotti, Mario Boccadoro, Daniele Derudas, Beatrice Anna Zannetti, Anna Baraldi, Francesco Nobile, Antonio Lazzaro, Annalisa Pezzi, Katia Mancuso, Francesco Lanza, Maria Concetta Petti
Publikováno v:
ResearcherID
The availability of novel drugs such as immunomodulatory drugs, IMiDs, and proteasome inhibitors, PI, for the front line treatment of Multiple Myeloma (MM) has dramatically changed patients’ outcomes, significantly prolonging progression free survi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d40fe8c19687df15cdd7c5109054c545
http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=ORCID&SrcApp=OrcidOrg&DestLinkType=FullRecord&DestApp=WOS_CPL&KeyUT=WOS:000349243500057&KeyUID=WOS:000349243500057
http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=ORCID&SrcApp=OrcidOrg&DestLinkType=FullRecord&DestApp=WOS_CPL&KeyUT=WOS:000349243500057&KeyUID=WOS:000349243500057
Autor:
Elena Zamagni, Cristina Nanni, Francesca Gay, Annalisa Pezzi, Marilena Bellò, Ilaria Rambaldi, Paola Tacchetti, Annamaria Brioli, Lucia Pantani, Valeria Magarotto, Beatrice Anna Zannetti, Massimo Menga, Giulia Marzocchi, Carolina Terragna, Katia Mancuso, Antonio Palumbo, Stefano Fanti, Michele Cavo
Publikováno v:
ResearcherID
Smoldering multiple myeloma (SMM) is an asymptomatic plasma cell disorder whose risk of progression to symptomatic MM (MM) is highly variable. Therefore, the identification of predictors of progression into MM is a relevant end point. Several markers
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6e98109c497726d6d1835e16aee5d9bf
http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=ORCID&SrcApp=OrcidOrg&DestLinkType=FullRecord&DestApp=WOS_CPL&KeyUT=WOS:000349243505157&KeyUID=WOS:000349243505157
http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=ORCID&SrcApp=OrcidOrg&DestLinkType=FullRecord&DestApp=WOS_CPL&KeyUT=WOS:000349243505157&KeyUID=WOS:000349243505157
Autor:
Sarah Parisi, Beatrice Anna Zannetti, Elisa Zuffa, Carmen Baldazzi, Giorgia Simonetti, Claudia Venturi, Eugenia Franchini, Chiara Sartor, Giovanni Martinelli, Nicoletta Testoni, Abbenante maria Chiara, A. Ferrari, Michele Cavo, Emanuela Ottaviani, Cristina Papayannidis, Katia Mancuso, Stefania Paolini, Margherita Perricone, Francesca Volpato, Viviana Guadagnuolo, Alberto Conficoni, Antonella Padella, Valentina Robustelli, Giovanni Marconi, Ilaria Iacobucci
Publikováno v:
ResearcherID
Background: AML is a heterogeneous disease. The karyotype provides important prognostic information that influences therapy and outcome. Identification of AML patients (pts) with poor prognosis such as those with complex karyotype (CK) has great inte
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bfec53e76b4ebc698a24b46251168d4a
http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=ORCID&SrcApp=OrcidOrg&DestLinkType=FullRecord&DestApp=WOS_CPL&KeyUT=WOS:000349242701035&KeyUID=WOS:000349242701035
http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=ORCID&SrcApp=OrcidOrg&DestLinkType=FullRecord&DestApp=WOS_CPL&KeyUT=WOS:000349242701035&KeyUID=WOS:000349242701035
Autor:
Lucia Pantani, Elena Zamagni, Michele Cavo, Annamaria Brioli, Beatrice Anna Zannetti, Annalisa Pezzi, Katia Mancuso, Giovanni Martinelli, Serena Rocchi, Paola Tacchetti
Publikováno v:
ResearcherID
Introduction sFLC assay is an important advance in the diagnosis and monitoring of MM, however data on prognostic significance are still limited. Methods We performed a retrospective analysis aimed to investigate the role of sFLC assay as predictor o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::79ba9ff17aa0c6d20d17bdf86ea9f8a6
http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=ORCID&SrcApp=OrcidOrg&DestLinkType=FullRecord&DestApp=WOS_CPL&KeyUT=WOS:000331385004046&KeyUID=WOS:000331385004046
http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=ORCID&SrcApp=OrcidOrg&DestLinkType=FullRecord&DestApp=WOS_CPL&KeyUT=WOS:000331385004046&KeyUID=WOS:000331385004046